Mannatech, Incorporated, the founder of the M5MSM (Mission 5 MillionSM) social entrepreneurial movement, the pioneer of nutritional glycobiology and the leading innovator of naturally-sourced supplements based on Real Food Technology® solutions, announces the issuance of two new patents pertaining to its Ambrotose AO formulations, increasing the total patents held by the company to 98.
Mannatech received the Certificate of Grant from both the Indian and Australian Patent Offices for their Ambrotose AO formulation pertaining to the Methods and Compositions for Modified Release of Nutritional Supplements. The Indian patent was issued on July 21, 2014 and the Australian patent was issued on September 18, 2014.
Both patents will remain in effect for 20 years from the date of filing. There are currently 33 patents issued worldwide to Mannatech for the technology pertaining to this formula. Overall, 98 patents have been issued worldwide to Mannatech for the technology pertaining to its Ambrotose®, Ambrotose AO, GI-ProBalance®, and PhytoMatrix® product formulations and in the field of biomarker assays.
“The vast majority of antioxidant supplements rely on high-dose synthetic ingredients,” said Dr. Rob Sinnott, CEO and Chief Science Officer at Mannatech. “We knew when we launched Ambrotose AO back in 2003 that a better approach would be to